IWIN — Irwin Naturals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Irwin Naturals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 5.92 | 7.24 | 10.1 | -2.52 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0.328 | -1.34 | 0.731 | -5.66 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -3.7 | 0.911 | 1.33 | -1.26 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 3.39 | 8.22 | 11 | -6.37 |
| Capital Expenditures | -0.037 | -0.134 | -0.051 | -0.147 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.414 | 0.053 | -0.001 | -0.778 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Cash from Investing Activities | 0.377 | -0.081 | -0.052 | -0.925 |
| Financing Cash Flow Items | — | — | — | -1.2 |
| Other Financing Cash Flow | ||||
| Total Cash Dividends Paid | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -3.4 | -8.07 | -10.7 | 7.45 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.366 | 0.071 | 0.183 | 0.175 |